Koers IR Biosciences Holdings Inc. Other OTC
Aandelen
IRBS
US46264M3034
Biotechnologie & Medisch Onderzoek
Omzet 2009 | - | Omzet 2010 | - | Marktkapitalisatie | 1,2 mln. 1,12 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | -6 mln. -5,6 mln. | Nettowinst (verlies) 2010 | -5 mln. -4,67 mln. | EV/omzet 2009 | - |
Nettoschuld 2009 | 5,81 mln. 5,42 mln. | Nettoschuld 2010 | 3,67 mln. 3,43 mln. | EV/omzet 2010 | - |
K/w-verhouding 2009 |
-0,37
x | K/w-verhouding 2010 |
-0,2
x | Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-07-03 | |
John N. Fermanis
DFI | Director of Finance/CFO | 70 | 01-12-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-07-03 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,65% | 39,36 mld. | |
-8,62% | 38,52 mld. | |
+26,95% | 30,74 mld. | |
+10,74% | 25,92 mld. | |
-13,50% | 26,03 mld. | |
+44,87% | 14,13 mld. | |
+34,36% | 12,73 mld. | |
-7,14% | 11,29 mld. | |
-12,61% | 10,64 mld. |